Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP

Oncogene volume 21, pages 1017–1027 (2002)Cite this article

Abstract

In early, androgen dependent stages of prostate cancer, androgen withdrawal, the major course of therapy in prostate cancer, leads to a rapid regression of the tumor as a result of apoptosis. However, prostate cancer invariably progresses to an androgen independent and apoptosis resistant stage for which no curative treatment is available. The molecular details of regression upon androgen withdrawal and progression to a resistant state are largely unknown. Here we show that c-Jun N-terminal Kinase (JNK) is activated strongly and in a sustained fashion by 12-O-tetradecanoylphorbol 13-acetate (TPA) and thapsigargin (TG), two agents which were previously shown to lead to apoptosis in the androgen responsive prostate cancer cell line LNCaP. The time course of JNK induction by both compounds correlated very well with the onset and progression of apoptosis in LNCaP cells. Inhibition of either ERK or p38 pathways did not affect TPA-induced cell death. In the androgen-independent prostate cancer cell lines DU-145 and PC-3, and in the cervical carcinoma cell line HeLaS3, TPA did not lead to apoptosis and there were no significant changes in JNK activity upon TPA treatment. The failure of TPA to induce JNK activity in PC-3, DU-145, and HelaS3 cells was not due to a general defect in JNK signaling since ultraviolet (UV) irradiation dramatically increased JNK activity in all four cell lines. Specific inhibition of JNK by expression of the JNK Inhibitory Protein (JIP) dramatically inhibited both TPA- and TG-induced apoptosis. Furthermore, apoptosis induced by both agents was completely blocked by ectopic expression of the baculovirus caspase-inhibitor P35. Surprisingly, ZVAD-fmk, a cell-permeable fluoromethylketone inhibitor of caspases, had no effect on TPA-induced apoptosis, whereas it completely inhibited TG-induced cell death; JNK activity was not affected in either case. This indicates that ZVAD-fmk does not inhibit some of the caspases involved in TPA-induced apoptosis, and that despite the common requirement of JNK activation, TPA- and TG-induced cell death are mechanistically different. Furthermore, it also suggests that JNK is either upstream or independent of caspases in LNCaP cells. Collectively, these results indicate that apoptosis in LNCaP cells requires a sustained increase in JNK activity and caspase activation; components of these signaling pathways may be defective in the androgen independent prostate cancer cell lines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Abreu-Martin MT, Chari A, Palladino AA, Craft NA, Sawyers CL . 1999 Mol. Cell. Biol. 19: 5143–5154

    Article  CAS  Google Scholar 

  • Araki S, Haneda M, Togawa M, Kikkawa R . 1997 Kidney Int. 51: 631–639

  • Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, Cohen JI . 1997 Proc. Natl. Acad. Sci. USA 94: 1172–1176

  • Chen YR, Zhou G, Tan TH . 1999 Mol. Pharmacol. 56: 1271–1279

  • Chinnaiyan AM, Dixit VM . 1996 Curr. Biol. 6: 555–562

  • Chow SC, Weis M, Kass GE, Holmstrom TH, Eriksson JE, Orrenius S . 1995 FEBS Lett. 364: 134–138

  • Clem RJ, Miller LK . 1994 Mol. Cell. Biol. 14: 5212–5222

    Article  CAS  Google Scholar 

  • Day ML, Zhao X, Wu S, Swanson PE, Humphrey PA . 1994 Cell. Growth Differ. 5: 735–741

  • Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ . 1994 Cell 76: 1025–1037

    Article  Google Scholar 

  • Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ . 1997 Science 277: 693–696

    Article  CAS  Google Scholar 

  • Ellis RE, Yuan JY, Horvitz HR . 1991 Annu. Rev. Cell. Biol. 7: 663–698

    Article  CAS  Google Scholar 

  • Franklin CC, Kraft AS . 1997 J. Biol. Chem. 272: 16917–16923

    Article  CAS  Google Scholar 

  • Fronsdal K, Engedal N, Saatcioglu F . 2000 Prostate 43: 111–117

  • Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, Kuroki T, Li L, Yuspa SH, Kazanietz MG . 2000 J. Biol. Chem. 275: 7574–7582

    Article  CAS  Google Scholar 

  • Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA . 1998 J. Biol. Chem. 273: 32608–32613

    Article  CAS  Google Scholar 

  • Garzotto M, White-Jones M, Jiang Y, Ehleiter D, Liao WC, Haimovitz-Friedman A, Fuks Z, Kolesnick R . 1998 Cancer Res. 58: 2260–2264

  • Gu Y, Sarnecki C, Aldape RA, Livingston DJ, Su MS . 1995 J. Biol. Chem. 270: 18715–18718

    Article  CAS  Google Scholar 

  • Henttu P, Vihko P . 1998 Biochem. Biophys. Res. Commun. 244: 167–171

  • Hibi M, Lin A, Smeal T, Minden A, Karin M . 1993 Genes Dev. 7: 2135–2148

  • Hirsch DD, Stork PJ . 1997 J. Biol. Chem. 272: 4568–4575

    Article  CAS  Google Scholar 

  • Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP . 1983 Cancer Res. 43: 1809–1818

  • Huggins C, Hodges CV . 1941 Cancer Res. 1: 293–297

  • Isaacs JT . 1994 Vitam. Horm. 49: 433–502

  • Jacobson MD, Weil M, Raff MC . 1997 Cell 88: 347–354

    Article  CAS  Google Scholar 

  • Karin M . 1998 Ann. N.Y. Acad. Sci. 851: 139–146

  • Kerr JF, Wyllie AH, Currie AR . 1972 Br. J. Cancer 26: 239–257

  • Kinzel V, Bonheim G, Richards J . 1988 Cancer Res. 48: 1759–1762

  • Kuroki DW, Bignami GS, Wattenberg EV . 1996 Cancer Res. 56: 637–644

  • Lenczowski JM, Dominguez L, Eder AM, King LB, Zacharchuk CM, Ashwell JD . 1997 Mol. Cell. Biol. 17: 170–181

    Article  CAS  Google Scholar 

  • Lewis TS, Shapiro PS, Ahn NG . 1998 Adv. Cancer Res. 74: 49–139

  • Li X, Yu H, Graves LM, Earp HS . 1997 J. Biol. Chem. 272: 14996–15002

    Article  CAS  Google Scholar 

  • Liu ZG, Hsu H, Goeddel DV, Karin M . 1996 Cell 87: 565–576

    Article  CAS  Google Scholar 

  • Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M . 1997 Lab. Invest. 76: 37–51

  • Magi-Galluzzi C, Montironi R, Cangi MG, Wishnow K, Loda M . 1998 Virchows Arch. 432: 407–413

  • Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng B, Denner L . 1999 Cancer Res. 59: 382–390

  • McConkey DJ, Greene G, Pettaway CA . 1996 Cancer Res. 56: 5594–5599

  • Miller LK . 1997 J. Cell Physiol. 173: 178–182

  • Minden A, Karin M . 1997 Biochim. Biophys. Acta 1333: F85–F104

  • Minden A, Lin A, Claret FX, Abo A, Karin M . 1995 Cell 81: 1147–1157

    Article  CAS  Google Scholar 

  • Montironi R, Pomante R, Diamanti L, Magi-Galluzzi C . 1998 Urol. Int. 60: Suppl 1 25–29

  • Moore RA . 1994 Surgery 16: 152–167

  • Nagahara A, Wang L, Del Valle J, Todisco A . 1998 Am. J. Physiol. 275: G740–G748

  • Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Sayyaparaju MR, Smulson ME, Yamin T-T, Violeta LY, Miller DK . 1995 Nature 376: 37–43

    Article  CAS  Google Scholar 

  • Robinson MJ, Cobb MH . 1997 Curr. Opin. Cell Biol. 9: 180–186

  • Roulston A, Reinhard C, Amiri P, Williams LT . 1998 J. Biol. Chem. 273: 10232–10239

    Article  CAS  Google Scholar 

  • Shrode LD, Rubie EA, Woodgett JR, Grinstein S . 1997 J. Biol. Chem. 272: 13653–13659

    Article  CAS  Google Scholar 

  • Sluss HK, Barrett T, Derijard B, Davis RJ . 1994 Mol. Cell. Biol. 14: 8376–8384

    Article  CAS  Google Scholar 

  • Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW . 1999 Science 284: 156–159

    Article  CAS  Google Scholar 

  • Srivastava RK, Sollott SJ, Khan L, Hansford R, Lakatta EG, Longo DL . 1999 Mol. Cell. Biol. 19: 5659–5674

    Article  CAS  Google Scholar 

  • Stattin P, Westin P, Damber JE, Bergh A . 1998 Br. J. Cancer 77: 670–675

  • Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben Neriah Y . 1994 Cell 77: 727–736

    Article  Google Scholar 

  • Treiman M, Caspersen C, Christensen SB . 1998 Trends Pharmacol. Sci. 19: 131–135

  • Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D . 2000 Science 287: 664–666

    Article  CAS  Google Scholar 

  • Wertz IE, Dixit VM . 2000 J. Biol. Chem. 275: 11470–11477

    Article  CAS  Google Scholar 

  • Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA . 1994 J. Biol. Chem. 269: 26396–26401

  • White E . 1996 Genes Dev. 10: 1–15

  • Widmann C, Gibson S, Jarpe MB, Johnson GL . 1999 Physiol. Rev. 79: 143–180

  • Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . 1995 Science 270: 1326–1331

    Article  CAS  Google Scholar 

  • Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ . 1999 Mol. Cell. Biol. 19: 7245–7254

    Article  CAS  Google Scholar 

  • Young CY, Murtha PE, Zhang J . 1994 Oncol. Res. 6: 203–210

  • Zhang P, Miller BS, Rosenzweig SA, Bhat NR . 1996 J. Neurosci. Res. 46: 114–121

    Article  CAS  Google Scholar 

  • Zhao X, Gschwend JE, Powell CT, Foster RG, Day KC, Day ML . 1997 J. Biol. Chem. 272: 22751–22757

    Article  CAS  Google Scholar 

  • Zhu H, Fearnhead HO, Cohen GM . 1995 FEBS Lett. 374: 303–308

Download references

Acknowledgements

We are grateful to Drs JI Cohen, R Davis and M Karin for generous gifts of plasmids. This work was supported by grants from the Norwegian Cancer Society and the University of Oslo to F Saatcioglu.

Author information

Authors and Affiliations

  1. Biotechnology Centre of Oslo, University of Oslo, Gaustadalleen 21, 0349 Oslo, Norway

    Nikolai Engedal, Ceren G Korkmaz & Fahri Saatcioglu

  2. Department of Biochemistry, University of Oslo, Gaustadalleen 21, 0349 Oslo, Norway

    Nikolai Engedal

  3. Institute of Clinical Medicine, University of Oslo, Gaustadalleen 21, 0349 Oslo, Norway

    Fahri Saatcioglu

Authors
  1. Nikolai Engedal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ceren G Korkmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fahri Saatcioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fahri Saatcioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engedal, N., Korkmaz, C. & Saatcioglu, F. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogene 21, 1017–1027 (2002). https://doi.org/10.1038/sj.onc.1205167

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205167

Keywords

This article is cited by

Search

Advanced search

Quick links